This inventor holds 6 USPTO granted patents. Top assignees: Case Western Reserve University, The University of Hong Kong, Versitech, Inc.. Active years: 2018-2024.
Location History:
- Cleveland, OH (US) (2019)
- Baltimore, MD (US) (2018 - 2022)
Company Filing History:
6 out of 1,364 
1 out of 375 
1 out of 144 Years Active: 2018-2024
Title: Yi-Lan Weng: Innovator in Phosphatase Inhibition
Introduction
Yi-Lan Weng is a prominent inventor based in Baltimore, MD (US). She has made significant contributions to the field of biochemistry, particularly in the area of phosphatase inhibition. With a total of 6 patents, her work has the potential to impact therapeutic strategies for various diseases.
Latest Patents
Among her latest patents is a groundbreaking method for inhibiting the activity of LAR family phosphatases. This method involves administering a therapeutic agent that targets the catalytic activity, signaling, and function of these phosphatases without interfering with their binding to proteoglycans. This innovative approach could lead to new treatments for conditions related to LAR family phosphatases.
Career Highlights
Yi-Lan Weng has held positions at esteemed institutions such as Case Western Reserve University and The University of Hong Kong. Her academic and research endeavors have positioned her as a leader in her field, contributing to advancements in therapeutic methodologies.
Collaborations
Throughout her career, Yi-Lan has collaborated with notable colleagues, including Bradley T. Lang and Jared M. Cregg. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.
Conclusion
Yi-Lan Weng's contributions to the field of phosphatase inhibition exemplify her dedication to advancing medical science. Her innovative patents and collaborative efforts continue to pave the way for future discoveries in therapeutic applications.